EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

In Vivo Messenger Ribonucleic Acid Vaccines: Advances and Future Directions

Fariborz Nowzari, Milad Zanjani, Kiana Samimi, Mohammadsaeid Zahedi, Mehdi Kian, Romina Tanideh, Hasan Dorali-nabi, Nader Tanideh

West Kazakhstan Regenerative Medicine Journal · 2025-10 · 13 (4) · 170-177

DOI: 10.4103/wkrj.wkrj_7_26 ↗

Kurz gefasst

Fachartikel in der Zeitschrift West Kazakhstan Regenerative Medicine Journal, online erschienen am 14.04.2026. Verfasst von Fariborz Nowzari und 7 weiteren Autor:innen. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This scoping review explores the rise of in vivo messenger ribonucleic acid (mRNA) cancer vaccines from 2015 to 2025, emphasizing their surge post-2021 driven by lipid nanoparticle delivery systems. Analyzing 40 clinical trials from PubMed and ClinicalTrials.gov, the review details antigen selection strategies (tumor-associated antigens, viral antigens, personalized neoantigens), immunostimulatory molecule-encoding vaccines (e.g., OX40 L, interleukin-12, CD40 L), combination therapies with immune checkpoint inhibitors, chimeric antigen receptor T-cell therapies, and dual mRNA vaccines, and innovations in mRNA design (optimized uridine, modified RNA, self-replicating RNA). Delivery challenges, including liver tropism and mRNA stability, are addressed alongside strategies such as ionizable lipids and multilayer liposomes. Artificial intelligence and machine learning enhance neoantigen prediction and vaccine design, promising personalized therapies.

Zitieren

APA

Nowzari, F., Zanjani, M., Samimi, K., Zahedi, M., Kian, M., Tanideh, R., Dorali-nabi, H., & Tanideh, N. (2025). In Vivo Messenger Ribonucleic Acid Vaccines: Advances and Future Directions. West Kazakhstan Regenerative Medicine Journal, 13(4), 170-177. https://doi.org/10.4103/wkrj.wkrj_7_26

Vancouver

Nowzari F, Zanjani M, Samimi K, Zahedi M, Kian M, Tanideh R, et al. In Vivo Messenger Ribonucleic Acid Vaccines: Advances and Future Directions. West Kazakhstan Regenerative Medicine Journal. 2025;13(4):170-177. doi:10.4103/wkrj.wkrj_7_26

BibTeX
@article{Nowzari2025,
  author = {Nowzari, Fariborz and Zanjani, Milad and Samimi, Kiana and Zahedi, Mohammadsaeid and Kian, Mehdi and Tanideh, Romina and Dorali-nabi, Hasan and Tanideh, Nader},
  title = {In Vivo Messenger Ribonucleic Acid Vaccines: Advances and Future Directions},
  journal = {West Kazakhstan Regenerative Medicine Journal},
  year = {2025},
  volume = {13},
  number = {4},
  pages = {170--177},
  doi = {10.4103/wkrj.wkrj_7_26}
}
Kostenlos starten →